Genetic & Genomic MedicineProceedings of the National Academy of SciencesPeer-reviewed
An intermediate effect size variant in UMOD confers risk for chronic kidney disease
Eric Gregory Olinger, Céline Schaeffer, Kendrah O. Kidd…·Magdalena Zarowiecki
The paper identifies an intermediate-effect variant in UMOD associated with chronic kidney disease risk and shows it has reduced disease severity compared to canonical ADTKD mutations.
49 citationstop 2%